Swedish Orphan Biovitrum AB (publ) (LON:0MTD)
London
· Delayed Price · Currency is GBP · Price in SEK 310.67
-3.20 (-1.02%)
At close: Feb 21, 2025
LON:0MTD Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 3,885 | 2,409 | 2,638 | 2,679 | 3,245 | Upgrade
|
| Depreciation & Amortization | 3,679 | 3,030 | 2,190 | 1,924 | 1,958 | Upgrade
|
| Other Amortization | - | 105 | 83 | 75 | 65 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 65 | 146 | 7 | - | Upgrade
|
| Other Operating Activities | 3 | 21 | 325 | -329 | 99 | Upgrade
|
| Change in Accounts Receivable | - | -900 | -1,982 | 452 | -185 | Upgrade
|
| Change in Inventory | - | 286 | 413 | -318 | -1,325 | Upgrade
|
| Change in Other Net Operating Assets | -179 | -546 | 763 | 980 | 1,069 | Upgrade
|
| Operating Cash Flow | 7,388 | 4,470 | 4,576 | 5,470 | 4,926 | Upgrade
|
| Operating Cash Flow Growth | 65.28% | -2.32% | -16.34% | 11.04% | 35.55% | Upgrade
|
| Capital Expenditures | -170 | -407 | -72 | -47 | -41 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 3 | 8 | Upgrade
|
| Cash Acquisitions | - | -16,961 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -2,835 | -4,536 | -1,405 | -323 | -3,811 | Upgrade
|
| Investment in Securities | - | - | - | - | -120 | Upgrade
|
| Other Investing Activities | -86 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -3,091 | -21,904 | -1,477 | -367 | -3,964 | Upgrade
|
| Long-Term Debt Issued | - | 35,876 | 13,675 | 14,193 | 13,575 | Upgrade
|
| Long-Term Debt Repaid | -4,606 | -24,790 | -16,227 | -18,316 | -15,145 | Upgrade
|
| Net Debt Issued (Repaid) | -4,606 | 11,086 | -2,552 | -4,123 | -1,570 | Upgrade
|
| Issuance of Common Stock | 427 | 6,129 | 89 | - | - | Upgrade
|
| Other Financing Activities | 178 | -203 | -439 | -351 | 288 | Upgrade
|
| Financing Cash Flow | -4,001 | 17,012 | -2,902 | -4,474 | -1,282 | Upgrade
|
| Foreign Exchange Rate Adjustments | -61 | -35 | 119 | 12 | -13 | Upgrade
|
| Net Cash Flow | 235 | -457 | 316 | 641 | -333 | Upgrade
|
| Free Cash Flow | 7,218 | 4,063 | 4,504 | 5,423 | 4,885 | Upgrade
|
| Free Cash Flow Growth | 77.65% | -9.79% | -16.95% | 11.01% | 35.81% | Upgrade
|
| Free Cash Flow Margin | 27.73% | 18.37% | 23.97% | 34.92% | 32.01% | Upgrade
|
| Free Cash Flow Per Share | 20.89 | 12.46 | 15.09 | 18.27 | 16.41 | Upgrade
|
| Cash Interest Paid | 1,091 | 949 | 309 | 324 | 333 | Upgrade
|
| Cash Income Tax Paid | 307 | 641 | 673 | 1,124 | 918 | Upgrade
|
| Levered Free Cash Flow | 1,709 | -0.38 | 3,535 | 4,485 | 287.63 | Upgrade
|
| Unlevered Free Cash Flow | 2,471 | 694 | 3,821 | 4,747 | 571.38 | Upgrade
|
| Change in Net Working Capital | 1,849 | 711 | 68 | -593 | 503 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.